Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Trial of Dasatinib in Advanced Sarcomas
This study is currently recruiting participants.
Study NCT00464620 Information provided by Sarcoma Alliance for Research through Collaboration
First Received: April 20, 2007 Last Updated: July 21, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Rhabdomyosarcoma
Chondrosarcoma
Sarcoma, Ewing's
Sarcoma, Alveolar Soft Part
Chordoma
Epithelioid Sarcoma
Giant Cell Tumor of Bone
Hemangiopericytoma
Additional conditions recognized in this trial
Bone Neoplasms
Gastrointestinal Stromal Tumors
Giant Cell Tumors
Nerve Sheath Neoplasms
Sarcoma
More general conditions related to this trial
Bone Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Musculoskeletal Diseases
Myosarcoma
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Bone Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms, Connective Tissue
Neoplasms, Germ Cell and Embryonal
Neoplasms, Muscle Tissue
Neoplasms, Nerve Tissue
Neoplasms, Vascular Tissue
Nervous System Diseases
Nervous System Neoplasms
Neuromuscular Diseases
Osteosarcoma
Peripheral Nervous System Diseases
Peripheral Nervous System Neoplasms
Interventions listed in this trial
Dasatinib
More general drug interventions related to this trial
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Kinase Inhibitors
Sponsors listed in this trial
Sarcoma Alliance for Research through Collaboration
Bristol-Myers Squibb
Back to top of Main Content
